SIGN UP
LOG IN
G
GTBP
Gt Biopharma Inc
2.28
0.00-0.08%Closed14:23 04/25 EDT
OPEN/PREV CLOSE2.300/2.282
TODAY RANGE2.280-2.320
VOL10.90K
MARKET CAP5.78M
52 WEEK RANGE1.720-10.66
AVG VOL (3M)457.67K
% TURNOVER0.43%
TURNOVER--
P/E (TTM)-0.3287
% RANGE3.07%
EPS(TTM)-6.9369
P/E(FORWARD)-0.9956
P/B-3.0506
BVPS-0.7474
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.73M
SHARES OUTSTANDING2.54M
NEXT EARNINGS05/13-05/19
FREE FLOAT2.08M
LOT SIZE1
EX-DIV DATE02/05/2024
News
Press Releases
Financial Reports
Profile
TipRanks·03/06 22:25
GT Biopharma files to sell 625,283 shares of common stock for holders
TipRanks·02/25 17:40
GT Biopharma could report Phase 1 trial data later this year, says Roth MKM
Barchart·02/25 13:00
GT Biopharma Announces Exercise of Warrants
TipRanks·01/27 12:12
GT Biopharma announces first patient dosed in Phase 1 trial of GTB-3650
Reuters·01/27 12:00
GT BIOPHARMA INC - INITIAL DATA FROM PHASE 1 TRIAL EXPECTED IN 2025
TipRanks·01/16 16:10
Biotech Alert: Searches spiking for these stocks today
Benzinga·01/14 12:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga·01/13 12:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
Dow Jones·12/23/2024 23:02
*GT Biopharma Offering Stock and Warrants
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.